GlassScriptPhysician profile
Katelyn Rose Freeman
NPI 1962935080
$9,892.27
in general payments reported to CMS, 2019-2025
30 companies · $1,662 in 2025
The $1,662 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,257 · 2022: $826 · 2023: $2,047 · 2024: $4,100 · 2025: $1,662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,809.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,822.32 | 2021-2024 | Aveir, Gallant, Ensite |
| Biosense Webster, INC. | $1,069.24 | 2022-2025 | Carto 3 |
| Medtronic, INC. | $973.19 | 2021-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Claria Mri Quad Crt-D Surescan |
| Boston Scientific Corporation | $590.89 | 2021-2025 | Accolade Sr, Watchman Access System |
| Cordis US Corp. | $475.07 | 2025 | Mynx Control Venous |
| Cardiva Medical, INC. | $432.92 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boehringer Ingelheim Pharmaceuticals, INC. | $379.17 | 2023-2025 | Jardiance |
| Pfizer INC. | $311.63 | 2021-2025 | |
| Irhythm Technologies, INC. | $254.24 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Merck Sharp & Dohme LLC | $244.68 | 2023-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $235.98 | 2021-2025 | Lifevest |
| Atricure, INC. | $155.74 | 2021 | |
| Sanofi-Aventis U.S. LLC | $137.21 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $118.92 | 2024-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $107.61 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $91.33 | 2024-2025 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $81.73 | 2021-2024 | Opsumit, Uptravi |
| Alnylam Pharmaceuticals INC. | $56.96 | 2024-2025 | Amvuttra |
| Kiniksa Pharmaceuticals International, Plc | $46.98 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $46.16 | 2024 | Evkeeza |
| Novo Nordisk INC | $42.86 | 2024-2025 | Wegovy |
| Amarin Pharma, INC. | $33.72 | 2022 | |
| Esperion Therapeutics, INC. | $32.35 | 2021-2025 | Nexletol |
| Amgen INC. | $32.21 | 2025 | Repatha |
| Cvrx, INC. | $25.25 | 2025 | Barostim Neo System |
| Zoll Respicardia, INC. | $24.57 | 2024 | Remede System |
| Janssen Pharmaceuticals, INC | $21.90 | 2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $18.74 | 2024 | |
| Angiodynamics, INC. | $14.44 | 2024 | Auryon Laser System 100-120 Vac |
| Impulse Dynamics (USA) INC. | $14.26 | 2025 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.